NKT Therapeutics' Series A Round

NKT Therapeutics raised a round of funding on March 20, 2009.

NKT Thereapeutics develops therapeutics based on a subset of immune cells called natural killer T cells.…

Articles about NKT Therapeutics' Series A Round: